BTG's Louise Makin On Joining IO Agents And Localized Intervention

 
• By Sten Stovall
  
Louise Makin
BTG CEO Says Joining Interventional Oncology And I/O Agents Is Promising • Source: BTG PLC
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business